NeoGenomics Inc (NEO) — Cash Flow Reinvestment Rate
NeoGenomics Inc (NEO) has a Cash Flow Reinvestment Rate of 5.86x as of December 2025, reinvesting $7.87 Million (capex $7.87 Million ) from operating cash flow of $1.34 Million. Explore NeoGenomics Inc (NEO) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NeoGenomics Inc Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for NeoGenomics Inc across 11 annual periods. Also explore NeoGenomics Inc (NEO) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NeoGenomics Inc (2011–2025)
Year-by-year capital reinvestment analysis for NeoGenomics Inc. For live market cap and broader valuation context, see NEO stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.90x | $46.57 Million | $5.23 Million | $27.01 Million | ▲ +16.0% |
| 2024 | 7.68x | $53.92 Million | $7.02 Million | $41.06 Million | ▼ -90.8% |
| 2020 | 83.86x | $122.44 Million | $1.46 Million | $29.10 Million | ▲ +4841.7% |
| 2019 | 1.70x | $39.66 Million | $23.37 Million | $20.03 Million | ▼ -50.6% |
| 2018 | 3.44x | $154.00 Million | $44.79 Million | $14.31 Million | ▲ +126.5% |
| 2017 | 1.52x | $27.38 Million | $18.04 Million | $13.69 Million | ▲ +132.3% |
| 2016 | 0.65x | $14.04 Million | $21.48 Million | $7.54 Million | ▲ +88.6% |
| 2015 | 0.35x | $2.21 Million | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $3.77 Million | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.01 Million | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $897.00K | $69.00K | $897.00K | — |